Xiyu Mei

671 total citations
15 papers, 518 citations indexed

About

Xiyu Mei is a scholar working on Ophthalmology, Pharmacology and Molecular Biology. According to data from OpenAlex, Xiyu Mei has authored 15 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Ophthalmology, 6 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Xiyu Mei's work include Retinal Diseases and Treatments (7 papers), Glaucoma and retinal disorders (5 papers) and Retinal Imaging and Analysis (3 papers). Xiyu Mei is often cited by papers focused on Retinal Diseases and Treatments (7 papers), Glaucoma and retinal disorders (5 papers) and Retinal Imaging and Analysis (3 papers). Xiyu Mei collaborates with scholars based in China. Xiyu Mei's co-authors include Bin Lü, Lili Ji, Tianyu Zhang, Hao Ouyang, Zhengtao Wang, Zengyang Yu, Kaixian Chen, Yuchen Sheng, Wenxian Huang and Lin Shao and has published in prestigious journals such as The FASEB Journal, Carbohydrate Polymers and Biochemical Pharmacology.

In The Last Decade

Xiyu Mei

13 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiyu Mei China 11 231 139 126 83 50 15 518
Meihua He China 6 244 1.1× 105 0.8× 78 0.6× 28 0.3× 41 0.8× 8 422
Suk-Yee Li Hong Kong 11 341 1.5× 268 1.9× 142 1.1× 34 0.4× 62 1.2× 12 822
Rosa Maisto Italy 16 302 1.3× 159 1.1× 54 0.4× 72 0.9× 13 0.3× 22 678
Adolfo Daniel Rodríguez-Carrizález Mexico 13 236 1.0× 181 1.3× 83 0.7× 36 0.4× 20 0.4× 20 766
Tomohiro Nakanishi Japan 13 308 1.3× 168 1.2× 82 0.7× 64 0.8× 26 0.5× 21 665
Xinguang Yang China 12 212 0.9× 163 1.2× 116 0.9× 98 1.2× 11 0.2× 20 532
Junko Hiraoka‐Yamamoto Japan 5 238 1.0× 132 0.9× 71 0.6× 35 0.4× 11 0.2× 6 605
Eriko Toda Japan 13 196 0.8× 157 1.1× 48 0.4× 19 0.2× 14 0.3× 14 400
Nobutaka Morimoto Japan 12 278 1.2× 32 0.2× 134 1.1× 64 0.8× 39 0.8× 18 819
Emma Arnal Spain 13 209 0.9× 240 1.7× 66 0.5× 23 0.3× 24 0.5× 22 671

Countries citing papers authored by Xiyu Mei

Since Specialization
Citations

This map shows the geographic impact of Xiyu Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiyu Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiyu Mei more than expected).

Fields of papers citing papers by Xiyu Mei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiyu Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiyu Mei. The network helps show where Xiyu Mei may publish in the future.

Co-authorship network of co-authors of Xiyu Mei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiyu Mei. A scholar is included among the top collaborators of Xiyu Mei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiyu Mei. Xiyu Mei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Dong, Shiyuan, Yue Zhang, Hao Ouyang, et al.. (2025). Uncovering the potential mechanism and bioactive compounds of Salviae Miltiorrhizae Radix et Rhizoma in attenuating diabetic retinopathy. Phytomedicine. 139. 156461–156461. 1 indexed citations
3.
4.
Zhang, Jingnan, Ze Zhang, Zhenlin Huang, et al.. (2023). Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1. Acta Pharmaceutica Sinica B. 13(7). 2990–3007. 20 indexed citations
5.
Mei, Xiyu, Hao Ouyang, Hong Zhang, et al.. (2023). Scutellarin suppresses the metastasis of triple-negative breast cancer via targeting TNFα/TNFR2-RUNX1-triggered G-CSF expression in endothelial cells. Biochemical Pharmacology. 217. 115808–115808. 9 indexed citations
6.
Mei, Xiyu, et al.. (2022). Scutellarin suppresses triple-negative breast cancer metastasis by inhibiting TNFα-induced vascular endothelial barrier breakdown. Acta Pharmacologica Sinica. 43(10). 2666–2677. 14 indexed citations
7.
Zhang, Jingnan, Fan Yang, Xiyu Mei, et al.. (2021). Toosendanin and isotoosendanin suppress triple-negative breast cancer growth via inducing necrosis, apoptosis and autophagy. Chemico-Biological Interactions. 351. 109739–109739. 31 indexed citations
8.
Yang, Xingliang, Xin Wang, Lin Shao, et al.. (2019). TRPV1 mediates astrocyte activation and interleukin-1β release induced by hypoxic ischemia (HI). Journal of Neuroinflammation. 16(1). 114–114. 90 indexed citations
9.
Zhang, Tianyu, Hao Ouyang, Xiyu Mei, et al.. (2019). Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia‐mediated ERK1/2–NF‐κB signaling pathway. The FASEB Journal. 33(11). 11776–11790. 105 indexed citations
10.
Zhang, Tianyu, Xiyu Mei, Hao Ouyang, et al.. (2018). Natural flavonoid galangin alleviates microglia-trigged blood–retinal barrier dysfunction during the development of diabetic retinopathy. The Journal of Nutritional Biochemistry. 65. 1–14. 42 indexed citations
11.
Mei, Xiyu, Tianyu Zhang, Hao Ouyang, et al.. (2018). Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy. Biochemical Pharmacology. 159. 82–95. 51 indexed citations
12.
Ouyang, Hao, Xiyu Mei, Tianyu Zhang, Bin Lü, & Lili Ji. (2018). Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier. European Journal of Pharmacology. 840. 20–27. 42 indexed citations
13.
Mei, Xiyu, et al.. (2017). Scutellaria barbata attenuates diabetic retinopathy by preventing retinal inflammation and the decreased expression of tight junction protein. International Journal of Ophthalmology. 10(6). 870–877. 22 indexed citations
14.
Mei, Xiyu, et al.. (2017). Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis. Vascular Pharmacology. 101. 29–37. 57 indexed citations
15.
Zhang, Tianyu, et al.. (2016). Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis. Journal of Ethnopharmacology. 189. 117–125. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meihua He Breakdown of academic impact, for papers by Suk-Yee Li Breakdown of academic impact, for papers by Rosa Maisto Breakdown of academic impact, for papers by Adolfo Daniel Rodríguez-Carrizález Breakdown of academic impact, for papers by Tomohiro Nakanishi Breakdown of academic impact, for papers by Xinguang Yang Breakdown of academic impact, for papers by Junko Hiraoka‐Yamamoto Breakdown of academic impact, for papers by Eriko Toda Breakdown of academic impact, for papers by Nobutaka Morimoto Breakdown of academic impact, for papers by Emma Arnal
Rankless by CCL
2026